J.-F. Bosset

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.

Aimery de Gramont, J.-F. Bosset, C Milan et al. · Journal of Clinical Oncology · 1997 · 904 citations

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

Bruno Chauffert, F. Mornex, F. Bonnetain et al. · Annals of Oncology · 2008 · 685 citations

Intensive Induction Chemoradiotherapy, Surgical Oncology, Pancreatic Cancer +10

Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance

J.-F. Bosset, G. Calais, A. Daban et al. · European Journal of Cancer · 2003 · 177 citations

Adaptive Radiotherapy, Rectal Cancer Patients, Surgical Oncology +9

Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies

J.-F. Bosset, J.J. Pavy, Han Hamers et al. · European Journal of Cancer · 1993 · 82 citations

Oncology, Radiation Therapy, Optimal Dose +7

Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial

J.-F. Bosset, G. Calais, Laurent Mineur et al. · Journal of Clinical Oncology · 2005 · 71 citations

Surgical Oncology, Prognosis, Surgical Science +18